Development on Selective Delivery System of Antitumor Agents by Utilizing Cell-Recognition Ability of Saccharides

点击翻译按钮获取中文摘要

Poly (alpha-malic acid) is of interest as a biodegradable and bioadsorbable poly (lactide) type drug carrier, which is able to covalently attach both drug and targeting moiety. The macromolecular prodrug of antitumor drug will reduce the side-effects, have the ability to target tumor cells and exhibit high antitumor activity. The design of poly (alpha-malic acid) /5-fluorouracil (5FU) /saccharide and poly (alpha-malic acid) /adriamycin (ADR) /saccharide conjugates were investigated. Monosaccharides such as galactosamine, glucosamine and mannosamine were used as targeting moieties. Growth inhibition against various tumor cells in vitro and the survival effect against mice bearing tumor cells in vivo were tested. Poly (alpha-malic acid) /5FU/galactosamine and poly (alpha-malic acid) /ADR/galactosamine conjugates showed stronger growth-inhibitory effects than poly (alpha-malic acid) /5FU and poly (alpha-malic acid) /ADR conjugates against human hepatoma cells in vitro. These results could be explained by galactose receptor-mediated specific uptake into hepatocyte cells. Moreover, the conjugates of poly (alpha-malic acid) with 5FU exhibited significant survival effects against p388 lymphocytic leukemia in mice by intraperitoneal (ip) transplantation/ip injection. The obtained conjugates did not display an acute toxicity in the high dose ranges.